betadex and succinoglycan

β-Cyclodextrin cross-linked succinoglycan dialdehyde hydrogels was prepared for hydrophobic drug delivery. Succinoglycan dialdehyde (SGDA) was synthesized from sodium periodate oxidation of succinoglycan isolated from Sinorhizobium meliloti Rm1021. Aminoethylcarbamoyl-β-cyclodextrin (ACD) was crosslinked with SGDA to form a succinoglycan dialdehyde/aminoethylcarbamoyl-β-cyclodextrin (SGDA/ACD) hydrogels. The SGDA/ACD hydrogels exhibited a 65.7 % improvement in storage modulus (G') and a 5.7-fold higher compressive strain than the SGDA/poly(ethylene glycol) diamine (PEG) hydrogels as controls. A hardly soluble drug, baicalein was used for the drug loading and release properties of SGDA/ACD hydrogels. Baicalein was released about 98 % within 48 h at pH 7.4, but not completely released even after 48 h at pH 2.0. In addition, at pH 7.4, only about 56 % of the baicalein loaded on the SGDA/PEG hydrogels was released within 48 h, while about 98 % of the baicalein loaded on the SGDA/ACD hydrogels was released within 48 h. It indicates that ACD significantly improved the solubilization efficacy of the baicalein. In vitro testing of cell viability using HEK-293 cells also showed that the SGDA/ACD hydrogels were suitable for the cells. In conclusion, SGDA/ACD hydrogels significantly enhance the utilization of baicalein and provide potential applications in drug delivery systems for hardly soluble drugs.

Topics: beta-Cyclodextrins; Drug Delivery Systems; HEK293 Cells; Humans; Hydrogels; Hydrogen-Ion Concentration; Polyethylene Glycols